Trademark: 90298731
Status Date
Monday, December 5, 2022
Filing Date
Wednesday, November 4, 2020
Abandoned Date
Monday, December 5, 2022
5 Testing kits comprised of diagnostic reagents and assays that test for the presence of COVID 19 and influenza; medical diagnostic reagents and kits comprised of diagnostic reagents and assays for use in disease testing, screening and monitoring COVID-19 and Influenza; diagnostic agents, preparations and substances for medical purposes; diagnostic kits comprised of diagnostic reagents for medical or medical diagnostic use in connection with the amplification, analysis, labeling and detection of nucleic acids for use in disease testing; all of the foregoing related to the detection of COVID-19 and influenza
1 Chemical products for diagnostic use, namely, diagnostic reagents, preparations, tests, kits for scientific or research use; diagnostic preparations for scientific and research use; reagents and kits comprised of diagnostic reagents and assays for laboratory or research use for use in disease testing, screening and monitoring; diagnostic kits comprised of reagents for scientific and research use in connection with the amplification, analysis, labeling and detection of nucleic acids; diagnostic kits comprised of diagnostic reagents for clinical or medical laboratory use in connection with the amplification, analysis, labeling and detection of nucleic acids; all of the foregoing related to the detection of COVID-19 and influenza
44 Medical diagnostic testing, screening, monitoring and reporting services; medical evaluation services, namely, conducting medical evaluations for patient triage, conducting medical physical evaluations, medical evaluation of COVID-19 and influenza; all of the foregoing services related to the detection of COVID-19 and influenza
42 Clinical and medical laboratory services; medical, scientific and technical research services in the field of COVID-19 and Influenza; biochemical research and development; chemical analysis; medical and scientific research services in the field of health care testing, screening and monitoring; pharmaceutical research and development; all of the foregoing services related to detection of COVID-19 and Influenza
COVID FLU - NINETEEN; COVID FLU - ONE NINE
Dec 29, 2022
Abandonment Notice Mailed - After Ex Parte Appeal
Dec 29, 2022
Abandonment Notice Mailed - After Ex Parte Appeal
Dec 5, 2022
Abandonment - After Ex Parte Appeal
Dec 5, 2022
Exparte Appeal Terminated
Oct 26, 2022
Exparte Appeal Dismissed - Failure To File Brief
Jul 7, 2022
Assigned To Examiner
Jun 16, 2022
Notification Of Subsequent Final Emailed
Jun 16, 2022
Subsequent Final Emailed
Jun 16, 2022
Subsequent Final Refusal Written
May 18, 2022
Teas/Email Correspondence Entered
May 18, 2022
Correspondence Received In Law Office
May 16, 2022
Teas Request For Reconsideration Received
May 16, 2022
Ex Parte Appeal-Instituted
May 16, 2022
Jurisdiction Restored To Examining Attorney
May 16, 2022
Exparte Appeal Received At Ttab
Nov 16, 2021
Notification Of Final Refusal Emailed
Nov 16, 2021
Final Refusal E-Mailed
Nov 16, 2021
Final Refusal Written
Oct 22, 2021
Teas/Email Correspondence Entered
Oct 22, 2021
Correspondence Received In Law Office
Oct 21, 2021
Assigned To Lie
Oct 18, 2021
Teas Response To Office Action Received
Oct 15, 2021
Teas/Email Correspondence Entered
Oct 15, 2021
Correspondence Received In Law Office
Oct 15, 2021
Teas Response To Office Action Received
Apr 20, 2021
Notification Of Non-Final Action E-Mailed
Apr 20, 2021
Non-Final Action E-Mailed
Apr 20, 2021
Non-Final Action Written
Mar 29, 2021
Assigned To Examiner
Jan 4, 2021
New Application Office Supplied Data Entered In Tram
Nov 7, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
